compound 1 [Vakkeel et al., 2018]   Click here for help

GtoPdb Ligand ID: 9895

Compound class: Synthetic organic
Comment: Compound 1 is a photoactivatable α5β1 integrin ligand [4]. Structurally it is a selective α5β1 integrin ligand (a peptidomimetic of the RGD adhesive motif found in several extracellular matrix (ECM) proteins) linked to a 3-(4,5-Dimethoxy-2-nitrophenyl)-2-butyl ester (DMNPB) photocleavable chromophore. When intact, the compound is unable to bind the integrin, but upon exposure to light the chromophore is cleaved and the ligand then behaves as an antagonist of α5β1 interaction with ECM substrates. The photactivation of compound 1 allows precise, in situ, dose-responsive and temporal study of the role played by α5β1 integrin-dependent processes in cell adhesion and migration.
α5β1 integrin is a molecular target that plays recognised roles in tumour angiogenesis and cancer cell migration and metastasis [3,5], that is being expoilted for clinical utility in cancer indications [2,6,8]. α5β1 may also be an immune system/inflammation relevant target [1,7].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 6
Rotatable bonds 25
Topological polar surface area 258.69
Molecular weight 790.34
XLogP 4.33
No. Lipinski's rules broken 3
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES [N-]=[N+]=NCCCOc1cc(C)c(c(c1)C)C(=O)NC(C(=O)OC(C(c1cc(OC)c(cc1[N+](=O)[O-])OC)C)C)CNC(=O)CNC(=O)c1cccc(c1)NC(=N)N
Isomeric SMILES [N-]=[N+]=NCCCOc1cc(C)c(c(c1)C)C(=O)NC(C(=O)OC(C(c1cc(OC)c(cc1[N+](=O)[O-])OC)C)C)CNC(=O)CNC(=O)c1cccc(c1)NC(=N)N
InChI InChI=1S/C37H46N10O10/c1-20-13-26(56-12-8-11-43-46-40)14-21(2)33(20)35(50)45-28(18-41-32(48)19-42-34(49)24-9-7-10-25(15-24)44-37(38)39)36(51)57-23(4)22(3)27-16-30(54-5)31(55-6)17-29(27)47(52)53/h7,9-10,13-17,22-23,28H,8,11-12,18-19H2,1-6H3,(H,41,48)(H,42,49)(H,45,50)(H4,38,39,44)
InChI Key CCIKYPZLPYEMFX-UHFFFAOYSA-N
References
1. Bachsais M, Naddaf N, Yacoub D, Salti S, Alaaeddine N, Aoudjit F, Hassan GS, Mourad W. (2016)
The Interaction of CD154 with the α5β1 Integrin Inhibits Fas-Induced T Cell Death.
PLoS ONE, 11 (7): e0158987. [PMID:27391025]
2. Levine RM, Kokkoli E. (2017)
Dual-ligand α5β1and α6β4integrin targeting enhances gene delivery and selectivity to cancer cells.
J Control Release, 251: 24-36. [PMID:28215671]
3. Miroshnikova YA, Rozenberg GI, Cassereau L, Pickup M, Mouw JK, Ou G, Templeman KL, Hannachi EI, Gooch KJ, Sarang-Sieminski AL et al.. (2017)
α5β1-Integrin promotes tension-dependent mammary epithelial cell invasion by engaging the fibronectin synergy site.
Mol Biol Cell, 28 (22): 2958-2977. [PMID:28877984]
4. Nair RV, Farrukh A, Del Campo A. (2018)
A Photoactivatable α5 β1 -Specific Integrin Ligand.
Chembiochem, 19 (12): 1280-1287. [PMID:29774654]
5. Renner G, Noulet F, Mercier MC, Choulier L, Etienne-Selloum N, Gies JP, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M. (2016)
Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.
Oncotarget, 7 (38): 62194-62207. [PMID:27613837]
6. Rocha LA, Learmonth DA, Sousa RA, Salgado AJ. (2018)
αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?.
Biotechnol Adv, 36 (1): 208-227. [PMID:29155160]
7. Sundaram A, Chen C, Khalifeh-Soltani A, Atakilit A, Ren X, Qiu W, Jo H, DeGrado W, Huang X, Sheppard D. (2017)
Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma.
J Clin Invest, 127 (1): 365-374. [PMID:27918306]
8. Yao H, Veine DM, Livant DL. (2016)
Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin.
Breast Cancer Res Treat, 157 (3): 489-501. [PMID:27255534]